Selective Macrocyclic WEE1 Kinase Inhibitors with Strong Efficacy against Patient-Derived Colorectal Cancer Organoids
Open Access
- 19 August 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (17) , 20160-20187
Abstract
Macrocyclization can enhance the selectivity of acyclic compounds toward structurally similar biological targets such as kinases. WEE1 regulates cellular homeostasis and is a promising target in oncology. The clinical candidate AZD1775 (1) failed to progress past Phase II trials because of patient tolerability issues, likely due to off-target inhibition of polo-like kinase 1 (PLK1). Herein, a computer-aided drug design approach was conducted to develop a macrocycle based on the 1-WEE1 X-ray cocrystal structure. Significantly enhanced WEE1 inhibitory selectivity over PLK1 was determined for leading macrocycle 2, which also demonstrated broader kinome-wide selectivity. Patient-derived organoids from colorectal cancer (CRC) peritoneal and liver metastases, treated with 2, demonstrated comparably strong or enhanced anticancer efficacy compared to that of 1. Against patient-matched normal colon vs primary CRC organoids, 2 potently and selectively treated CRC, as well as enhanced DNA damage compared to 1. Finally, the X-ray cocrystal structure of 2 bound to WEE1 validated its computationally predicted bioactive binding mode.Keywords
Funding Information
- National Health and Medical Research Council
- South Australian Health and Medical Research Institute
- Therapeutic Innovation Australia (TIA), Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program
- Australian Government Research Training Program Scholarship
- The Gastroenterological Society of Australia Bushell Research Fellowship
- Faculty of Health Science at the University of Adelaide
- Monash Graduate Excellence Scholarship provided by Monash University
This publication has 85 references indexed in Scilit:
- H2AX: A key player in DNA damage response and a promising target for cancer therapyBiomedicine & Pharmacotherapy, 2024
- An update of predictive biomarkers related to WEE1 inhibition in cancer therapyJournal of Cancer Research and Clinical Oncology, 2024
- E2F8 exerts cancer-promoting effects by transcriptionally activating RRM2 and E2F8 knockdown synergizes with WEE1 inhibition in suppressing lung adenocarcinomaBiochemical Pharmacology, 2023
- The expanding role of WEE1Cellular Signalling, 2022
- Development of Potent Pyrazolopyrimidinone‐Based WEE1 Inhibitors with Limited Single‐Agent Cytotoxicity for Cancer TherapyChemMedChem, 2018
- Kinase Inhibitor Selectivity Profiling Using Differential Scanning Fluorimetry2011
- Macrocyclic Aminopyrimidines as Multitarget CDK and VEGF‐R Inhibitors with Potent Antiproliferative ActivitiesChemMedChem, 2006
- Integrated Modeling Program, Applied Chemical Theory (IMPACT)Journal of Computational Chemistry, 2005
- Ewald summation techniques in perspective: a surveyComputer Physics Communications, 1996
- ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformationJournal of Computational Chemistry, 1994